Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AZRX Stock Forecast 2025-2026
$0.40
Current Price
$31.19M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to AZRX Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
AZRX Price Momentum
+2.6%
1 Week Change
-23.1%
1 Month Change
-61.5%
1 Year Change
-35.5%
Year-to-Date Change
-68.3%
From 52W High of $1.27
+117.7%
From 52W Low of $0.19
📊 TOP ANALYST CALLS
Did AZRX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AzurRx is one of their latest high-conviction picks.
Latest AZRX Stock Price Targets & Analyst Predictions
AZRX has shown a year-to-date change of -35.5% and a 1-year change of -61.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AZRX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AZRX Analyst Ratings
0
Buy
0
Hold
0
Sell
AZRX Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.40
Latest AZRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AZRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
AzurRx BioPharma Inc (AZRX) Competitors
The following stocks are similar to AzurRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AzurRx BioPharma Inc (AZRX) Financial Data
AzurRx BioPharma Inc has a market capitalization of $31.19M with a P/E ratio of 0.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +43.3%.
Valuation Metrics
Market Cap
$31.19M
Enterprise Value
$25.76M
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
0.0%
Current Ratio
0.4x
Debt/Equity
0.0x
ROE
+43.3%
ROA
-680.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
AzurRx BioPharma Inc (AZRX) Business Model
About AzurRx BioPharma Inc
What They Do
Business Model
Additional Information
Company Information
AzurRx BioPharma Inc (AZRX) Latest News & Analysis
Latest News
Quick Summary
The company will start trading on Nasdaq under the new ticker symbol "FBWI" effective September 22.
Why It Matters
The new ticker symbol “FBWI” on Nasdaq indicates a potential rebranding or restructuring, which may influence investor perception and trading behavior.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
In September 2021, three penny stocks are highlighted as noteworthy by top investors for potential watchlist inclusion.
Why It Matters
The mention of top investors buying penny stocks highlights potential growth opportunities and signals market interest, which could influence investment decisions and stock performance.
Source: PennyStocks
Market Sentiment:
Positive
Quick Summary
AzurRx BioPharma Inc is set to acquire First Wave Bio Inc for $229 million in a stock and cash deal, focusing on therapies for autoimmune inflammatory bowel diseases.
Why It Matters
AzurRx's acquisition of First Wave Bio enhances its pipeline in the lucrative biotech sector, potentially increasing value and market position, affecting investor sentiment and stock performance.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
AzurRx BioPharma CEO James Sapirstein discussed the acquisition of First Wave Bio during a recent conference call, outlining strategic objectives and potential impacts on the company.
Why It Matters
The acquisition can signal growth potential and strategic direction for AzurRx, impacting share price, investor confidence, and future financial performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma will be renamed "First Wave BioPharma" and will begin trading under the new NASDAQ ticker symbol "FWBI."
Why It Matters
The rebranding and new ticker symbolize a strategic shift, potentially attracting investor interest and impacting stock performance due to a fresh identity and focus.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma, Inc. (NASDAQ:AZRX) announced a merger with First Wave Bio, Inc., adopting the name First Wave BioPharma, as stated in a shareholder letter from CEO James Sapirstein.
Why It Matters
The merger announcement signals a strategic shift for AzurRx BioPharma, potentially enhancing its market position and expanding its product pipeline in the GI disease sector, impacting future valuations.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About AZRX Stock
What is AzurRx BioPharma Inc's (AZRX) stock forecast for 2026?
Analyst forecasts for AzurRx BioPharma Inc (AZRX) are not currently available. The stock is trading at $0.40.
Is AZRX stock a good investment in 2026?
Analyst ratings for AZRX are not currently available. The stock is currently trading at $0.40. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AZRX stock?
Price predictions from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.40.
What is AzurRx BioPharma Inc's business model?
N/A
What is the highest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.40.
What is the lowest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.40.
What is the overall AZRX consensus from analysts for AzurRx BioPharma Inc?
Analyst ratings for AZRX are not currently available. The stock is trading at $0.40.
How accurate are AZRX stock price projections?
Stock price projections, including those for AzurRx BioPharma Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 8, 2025 2:51 AM UTC